跳至主要内容
临床试验/CTRI/2021/04/032610
CTRI/2021/04/032610已完成未知

Comparative therapeutic efficacy of intralesional bleomycin and intralesional vitamin D-3 in verruca vulgaris.

Department of Dermatology Venereology and Leprosy0 个研究点目标入组 32 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All untreated consecutive patients having single/ multiple lesions of verruca vulgaris.
  • 2. Patients above the age of 14 years.

排除标准

  • 1. Pregnant or lactating females.
  • 2. Immunocompromised individuals including HIV.
  • 3. Patients known to have hypersensitivity to vitamin D-3.
  • 4. Patients having history of peripheral vascular disorders like scleroderma or Raynaudââ?¬•s phenomenon.
  • 5. Patients with pulmonary fibrosis.
  • 6. History of intake of vitamin D-3, anabolic steroids, bisphosphonates in the last 3 months or history of intravenous chemotherapy with bleomycin in the past.
  • 7. Patients having any significant systemic illness.

研究者

发起方
Department of Dermatology Venereology and Leprosy

相似试验